The Department of Adult Intensive Care Medicine, University Hospital Medical Center, Lausanne, 1011, Switzerland.
The Faculty of Biology and Medicine, University of Lausanne, Lausanne, 1011, Switzerland.
BMC Pulm Med. 2023 Aug 16;23(1):301. doi: 10.1186/s12890-023-02591-5.
The outcome of Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO) in acute respiratory failure may be influenced by patient-related factors, center expertise and modalities of mechanical ventilation (MV) during ECMO. We determined, in a medium-size ECMO center in Switzerland, possible factors associated with mortality during VV-ECMO for acute respiratory failure of various etiologies.
We retrospectively analyzed all patients treated with VV-ECMO in our University Hospital from 2012 to 2019 (pre-COVID era). Demographic variables, severity scores, MV duration before ECMO, pre and on-ECMO arterial blood gases and respiratory variables were collected. The primary outcome was ICU mortality. Data were compared between survivors and non-survivors, and factors associated with mortality were assessed in univariate and multivariate analyses.
Fifty-one patients (33 ARDS, 18 non-ARDS) were included. ICU survival was 49% (ARDS, 39%; non-ARDS 67%). In univariate analyses, a higher driving pressure (DP) at 24h and 48h on ECMO (whole population), longer MV duration before ECMO and higher DP at 24h on ECMO (ARDS patients), were associated with mortality. In multivariate analyses, ECMO indication, higher DP at 24h on ECMO and, in ARDS, longer MV duration before ECMO, were independently associated with mortality.
DP on ECMO and longer MV duration before ECMO (in ARDS) are major, and potentially modifiable, factors influencing outcome during VV-ECMO.
静脉-静脉体外膜肺氧合(VV-ECMO)在急性呼吸衰竭中的结果可能受到患者相关因素、中心专业知识以及 ECMO 期间机械通气(MV)方式的影响。我们在瑞士的一个中型 ECMO 中心,确定了与各种病因的急性呼吸衰竭患者接受 VV-ECMO 期间死亡率相关的可能因素。
我们回顾性分析了 2012 年至 2019 年期间(COVID 前时代)在我们大学医院接受 VV-ECMO 治疗的所有患者。收集了人口统计学变量、严重程度评分、ECMO 前 MV 持续时间、ECMO 前和 ECMO 期间的动脉血气和呼吸变量。主要结局是 ICU 死亡率。将幸存者和非幸存者的数据进行比较,并在单变量和多变量分析中评估与死亡率相关的因素。
共纳入 51 例患者(33 例 ARDS,18 例非 ARDS)。ICU 存活率为 49%(ARDS,39%;非 ARDS,67%)。在单变量分析中,ECMO 后 24 小时和 48 小时的驱动压(DP)较高(整个人群)、ECMO 前 MV 持续时间较长以及 ECMO 后 24 小时 DP 较高与死亡率相关。在多变量分析中,ECMO 指征、ECMO 后 24 小时 DP 较高以及 ARDS 患者 ECMO 前 MV 持续时间较长与死亡率独立相关。
ECMO 上的 DP 和 ECMO 前 MV 持续时间较长(在 ARDS 中)是影响 VV-ECMO 期间结果的主要因素,且可能是可改变的因素。